Clinical Trial Update: Oropharyngeal and Nasopharyngeal Decontamination With Chlorhexidine Gluconate in the Reduction of the Postoperative Morbidity and Mortality After Major Pulmonary Resections [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated whether oropharyngeal and nasopharyngeal decontamination with chlorhexidine gluconate can reduce morbidity and mortality afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Chlorhexidine Gluconate (Chlorhexidine gluconate)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Infections and Respiratory Infectious | Phase 3 | Status: COMPLETED